SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biosynergy Inc – ‘10-Q’ for 1/31/20 – ‘EX-101.DEF’

On:  Thursday, 3/12/20, at 3:06pm ET   ·   For:  1/31/20   ·   Accession #:  715812-20-2   ·   File #:  0-12459

Previous ‘10-Q’:  ‘10-Q’ on 12/16/19 for 10/31/19   ·   Next:  ‘10-Q’ on 9/10/20 for 7/31/20   ·   Latest:  ‘10-Q/A’ on 3/28/22 for 1/31/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/12/20  Biosynergy Inc                    10-Q        1/31/20   41:1.1M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    124K 
 2: EX-31.1     Certification of Chief Executive Officer            HTML     18K 
 3: EX-31.2     Certification of Chief Accounting Officer           HTML     18K 
 5: EX-32       Certification -- §906 - SOA'02                      HTML     13K 
 4: EX-32.1     Certification Pursuant to 18 U.S.C. Section 1350    HTML     13K 
                as Adopted                                                       
27: R1          Document and Entity Information                     HTML     45K 
38: R2          Balance Sheets (Unaudited)                          HTML    101K 
34: R3          Balance Sheets (Parenthetical)                      HTML     21K 
16: R4          Statements of Operations (Unaudited)                HTML     57K 
26: R5          Statements of Cash Flows (Unaudited)                HTML     66K 
37: R6          Shareholders Equity (Unaudited)                     HTML     24K 
33: R7          Company Organization and Description                HTML     19K 
15: R8          Summary of Significant Accounting Policies          HTML     40K 
28: R9          Inventories                                         HTML     19K 
14: R10         Common Stock                                        HTML     16K 
24: R11         Related Party Transactions                          HTML     24K 
36: R12         Lease Commitments                                   HTML     18K 
32: R13         Customer Concentration                              HTML     19K 
13: R14         Depreciation                                        HTML     16K 
23: R15         Research and Development and Patents                HTML     17K 
35: R16         Summary of Significant Accounting Policies          HTML     88K 
                (Policies)                                                       
31: R17         Summary of Significant Accounting Policies          HTML     23K 
                (Tables)                                                         
12: R18         Inventories (Tables)                                HTML     20K 
25: R19         Related Party Transactions (Tables)                 HTML     22K 
40: R20         Summary of Significant Accounting Policies -        HTML     27K 
                Income Tax Rate (Details)                                        
30: R21         Summary of Significant Accounting Policies -        HTML     23K 
                Provision for Income Taxes (Details)                             
18: R22         Depreciation (Details Narrative)                    HTML     16K 
22: R23         Research and Development and Patents (Details       HTML     17K 
                Narrative)                                                       
39: R24         Inventories - Inventories (Details)                 HTML     22K 
29: R25         Related Party Transactions (Details Narrative)      HTML     22K 
17: R26         Lease Commitments - Future Minimum Lease Expense    HTML     20K 
                (Details)                                                        
21: R27         Customer Concentrations (Details)                   HTML     21K 
41: XML         IDEA XML File -- Filing Summary                      XML     64K 
20: EXCEL       IDEA Workbook of Financial Reports                  XLSX     31K 
11: EX-101.INS  XBRL Instance -- bsyn-20200131                       XML    236K 
 7: EX-101.CAL  XBRL Calculations -- bsyn-20200131_cal               XML     98K 
 8: EX-101.DEF  XBRL Definitions -- bsyn-20200131_def                XML     56K 
 9: EX-101.LAB  XBRL Labels -- bsyn-20200131_lab                     XML    304K 
10: EX-101.PRE  XBRL Presentations -- bsyn-20200131_pre              XML    223K 
 6: EX-101.SCH  XBRL Schema -- bsyn-20200131                         XSD     55K 
19: ZIP         XBRL Zipped Folder -- 0000715812-20-000002-xbrl      Zip     41K 


‘EX-101.DEF’   —   XBRL Definitions — bsyn-20200131_def


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.2a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
<!-- Field: Doc-Info; Name: Source; Value: bsyn013120V2.xfr; Date: 2020%2D03%2D12T18:46:13Z -->
<!-- Field: Doc-Info; Name: Status; Value: 0x800C0003 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://biosynergyinc.com/role/DocumentAndEntityInformation" xlink:href="bsyn-20200131.xsd#DocumentAndEntityInformation" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/BalanceSheets" xlink:href="bsyn-20200131.xsd#BalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/BalanceSheetsParenthetical" xlink:href="bsyn-20200131.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/StatementsOfOperations" xlink:href="bsyn-20200131.xsd#StatementsOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/StatementsOfCashFlows" xlink:href="bsyn-20200131.xsd#StatementsOfCashFlows" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/ShareholdersEquity" xlink:href="bsyn-20200131.xsd#ShareholdersEquity" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/CompanyOrganizationAndDescription" xlink:href="bsyn-20200131.xsd#CompanyOrganizationAndDescription" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="bsyn-20200131.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/Inventories" xlink:href="bsyn-20200131.xsd#Inventories" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/CommonStock" xlink:href="bsyn-20200131.xsd#CommonStock" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/RelatedPartyTransactions" xlink:href="bsyn-20200131.xsd#RelatedPartyTransactions" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/LeaseCommitments" xlink:href="bsyn-20200131.xsd#LeaseCommitments" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/MajorCustomers" xlink:href="bsyn-20200131.xsd#MajorCustomers" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/Depreciation" xlink:href="bsyn-20200131.xsd#Depreciation" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/ResearchAndDevelopmentAndPatents" xlink:href="bsyn-20200131.xsd#ResearchAndDevelopmentAndPatents" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="bsyn-20200131.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="bsyn-20200131.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/InventoriesTables" xlink:href="bsyn-20200131.xsd#InventoriesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/RelatedPartyTransactionsTables" xlink:href="bsyn-20200131.xsd#RelatedPartyTransactionsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/SummaryOfSignificantAccountingPoliciesTables-IncomeTaxRateDetails" xlink:href="bsyn-20200131.xsd#SummaryOfSignificantAccountingPoliciesTables-IncomeTaxRateDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/SummaryOfSignificantAccountingPoliciesTables-ProvisionForIncomeTaxesDetails" xlink:href="bsyn-20200131.xsd#SummaryOfSignificantAccountingPoliciesTables-ProvisionForIncomeTaxesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/DepreciationDetailsNarrative" xlink:href="bsyn-20200131.xsd#DepreciationDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/ResearchAndDevelopmentAndPatentsDetailsNarrative" xlink:href="bsyn-20200131.xsd#ResearchAndDevelopmentAndPatentsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/Inventories-InventoriesDetails" xlink:href="bsyn-20200131.xsd#Inventories-InventoriesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="bsyn-20200131.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/LeaseCommitments-FutureMinimumLeaseExpenseDetails" xlink:href="bsyn-20200131.xsd#LeaseCommitments-FutureMinimumLeaseExpenseDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://biosynergyinc.com/role/CustomerConcentrationsDetails" xlink:href="bsyn-20200131.xsd#CustomerConcentrationsDetails" xlink:type="simple"/>
<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll"/>
<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets (Unaudited)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations (Unaudited)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Statements of Cash Flows (Unaudited)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/ShareholdersEquity" xlink:title="00000006 - Statement - Shareholders Equity (Unaudited)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="0"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_70"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue_70" xlink:type="arc" order="2"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="3"/>
</link:definitionLink>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/CompanyOrganizationAndDescription" xlink:title="00000007 - Disclosure - Company Organization and Description"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/Inventories" xlink:title="00000009 - Disclosure - Inventories"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/CommonStock" xlink:title="00000010 - Disclosure - Common Stock"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/RelatedPartyTransactions" xlink:title="00000011 - Disclosure - Related Party Transactions"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/LeaseCommitments" xlink:title="00000012 - Disclosure - Lease Commitments"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/MajorCustomers" xlink:title="00000013 - Disclosure - Customer Concentration"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/Depreciation" xlink:title="00000014 - Disclosure - Depreciation"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/ResearchAndDevelopmentAndPatents" xlink:title="00000015 - Disclosure - Research and Development and Patents"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000016 - Disclosure - Summary of Significant Accounting Policies (Policies)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000017 - Disclosure - Summary of Significant Accounting Policies (Tables)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/InventoriesTables" xlink:title="00000018 - Disclosure - Inventories (Tables)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/RelatedPartyTransactionsTables" xlink:title="00000019 - Disclosure - Related Party Transactions (Tables)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/SummaryOfSignificantAccountingPoliciesTables-IncomeTaxRateDetails" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies - Income Tax Rate (Details)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/SummaryOfSignificantAccountingPoliciesTables-ProvisionForIncomeTaxesDetails" xlink:title="00000021 - Disclosure - Summary of Significant Accounting Policies - Provision for Income Taxes (Details)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/DepreciationDetailsNarrative" xlink:title="00000022 - Disclosure - Depreciation (Details Narrative)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/ResearchAndDevelopmentAndPatentsDetailsNarrative" xlink:title="00000023 - Disclosure - Research and Development and Patents (Details Narrative)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/Inventories-InventoriesDetails" xlink:title="00000024 - Disclosure - Inventories - Inventories (Details)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000025 - Disclosure - Related Party Transactions (Details Narrative)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/LeaseCommitments-FutureMinimumLeaseExpenseDetails" xlink:title="00000026 - Disclosure - Lease Commitments - Future Minimum Lease Expense (Details)"/>
<link:definitionLink xlink:type="extended" xlink:role="http://biosynergyinc.com/role/CustomerConcentrationsDetails" xlink:title="00000027 - Disclosure - Customer Concentrations (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30"/>
<link:loc xlink:type="locator" xlink:href="bsyn-20200131.xsd#bsyn_Customer2Member" xlink:label="loc_bsynCustomer2Member_20"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_bsynCustomer2Member_20" xlink:type="arc" order="21"/>
<link:loc xlink:type="locator" xlink:href="bsyn-20200131.xsd#bsyn_Customer1Member" xlink:label="loc_bsynCustomer1Member_30"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_bsynCustomer1Member_30" xlink:type="arc" order="31"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableGross" xlink:label="loc_us-gaapAccountsReceivableGross_130"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableGross_130" xlink:type="arc" order="0"/>
<link:loc xlink:type="locator" xlink:href="bsyn-20200131.xsd#bsyn_Sales" xlink:label="loc_bsynSales_130"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_bsynSales_130" xlink:type="arc" order="1"/>
<link:loc xlink:type="locator" xlink:href="bsyn-20200131.xsd#bsyn_Exports" xlink:label="loc_bsynExports_130"/>
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_bsynExports_130" xlink:type="arc" order="2"/>
</link:definitionLink>
</link:linkbase>

Top
Filing Submission 0000715812-20-000002   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 3:07:41.2am ET